The efficacy of angiogenesis inhibitors combined with chemotherapy in advanced breast cancer: a systematic review and meta-analysis - Summary - MDSpire
Advertisement
The efficacy of angiogenesis inhibitors combined with chemotherapy in advanced breast cancer: a systematic review and meta-analysis
The addition of angiogenesis inhibitors to chemotherapy improves PFS and response rates in advanced breast cancer, particularly in specific subtypes, but does not enhance overall survival.
Limitations:
Comparative efficacy across drug classes and optimal patient selection remain undefined.
Increased toxicity may limit treatment options and necessitate proactive management.
Conclusion:
Adding angiogenesis inhibitors to chemotherapy improves PFS and response in advanced breast cancer, especially in TNBC and HR+ disease, but does not affect OS.